Business

WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease

WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Imp...

articleHealwell Ai Inc. Class AJuly 17, 20244/company/healwell-ai-inc/news/well-health-launches-its-ai-powered-co-pilot-for-cardiologists-powered-by-healwell-ai-to-help-improve-detection-of-cardiovascular-disease
WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease

About this update from Healwell Ai Inc. Class A

[{"type":"text","content":"\n \n \n \n WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease (\"CVD\"). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of the WELL AI Decision Support (\"WAIDS\") product offering.\n \n \n The co-pilot will be deployed into WELL Diagnostic Centres,\n \n Canada's\n \n largest cardiology and medical diagnostic group, providing support and assisting cardiologists in over 40 locations across\n \n Ontario\n \n .\n \n \n CVD stands as the leading cause of death globally, accounting for approximately 32% of deaths worldwide in 2019\n \n (1)\n \n , underscoring the critical need for early detection. HEALWELL also expects to leverage this technology to help accelerate life sciences research and development opportunities related to CVD and drive new business opportunities for its newly acquired Clinical Research Organization (\"CRO\"), BioPharma Services Inc.\n \n \n \n \n \n VANCOUVER, BC\n \n and\n \n TORONTO\n \n \n ,\n \n \n July 17, 2024\n \n \n /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (\"\n \n WELL\n \n \" or the \"\n \n Company\n \n \") a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"\n \n HEALWELL\n \n \"), a healthcare technology company focused on AI and data science for preventative care, are jointly pleased to announce the launch of WELL's AI-powered co-pilot for cardiologists exclusively powered by HEALWELL AI, aimed at identifying patients at high risk of cardiovascular disease (\"\n \n CVD\n \n \"). This significant expansion of WELL's AI capabilities builds on the success of its second-generation AI-powered physician co-pilot, WELL AI Decision Support\n \n...

More updates from Healwell Ai Inc. Class A